NHS National Generic Pharmaceuticals Wave 15a

Published date: 4 July 2024

Contract summary

Industry

Pharmaceutical products - 33600000

Location of contract

East Midlands, East of England, London, North East, North West, South East, South West, West Midlands, Yorkshire and the Humber, Channel Islands

Value of contract

£379,041,943

Procurement reference

CF-2421300D0O000000rwimUAA

Published date

4 July 2024

Closing date

8 August 2024

Closing time

1pm

Contract start date

1 February 2025

Contract end date

31 May 2027

Contract type

Supply contract

Procedure type

Open procedure (above threshold)

Contract is suitable for SMEs?

Yes

Contract is suitable for VCSEs?

No

---

Description

Invitation to offer for NHS National Generic Pharmaceuticals - Wave 15a.
Offer reference number: CM/PHG/23/5697.
Period of framework agreement: The total maximum duration of the framework agreement to be no more than 28 months with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 48 months.

Potential periods of call-offs under the framework agreement:

CM/PHG/23/5697/01 - Orals (plus non-parenteral) Products:
All Regions (CESW/LSNE/NWLN): 01/02/2025 to 31/05/2027 (28 Months)

CM/PHG/23/5697/02 - Hospital Only Products:
DNW & DLN: 01/02/2025 to 31/01/2027 (24 months)

CM/PHG/23/5697/03 - Hospital Only Products (Housekeeping):
DLS & DNE: 01/02/2025 to 31/05/2026 (16 months)
DCE & DSW: 01/02/2025 to 30/09/2025 (8 months)

---

More information

Attachments

Document No. 04a - Quality Assurance Process.doc

Document No. 04a - Quality Assurance Process

Document No. 01 - Invitation to offer covering letter.docx

Document No. 01 - Invitation to offer covering letter

Document No. 03 - Framework Agreement and Terms and Conditions.pdf

Document No. 03 - Framework Agreement and Terms and Conditions

Document No. 07b - Quality Assurance Policy to support the National Contract Procurement of Licensed Medicines v6 (Issued October 2023).docx

Document No. 07b - Quality Assurance Policy to support the National Contract Procurement of Licensed Medicines v6 (Issued October 2023)

Document No. 06 - Form of offer.doc

Document No. 06 - Form of offer

Document No. 05a (iii) Product Listing and Usage - Hospital Only (DNW & DLN) CM_PHG_23_5697_02.xlsx

Document No. 05a (iii) Product Listing and Usage - Hospital Only (DNW & DLN) CM_PHG_23_5697_02

Document No. 07a - Quality control technical sheet.doc

Document No. 07a - Quality control technical sheet

Document No. 05a (i) - Product Listing and Usage - Orals (plus non-parenteral) Products (CESW, LSNE & NWLN) CM_PHG_23_5697_01.xlsx

Document No. 05a (i) - Product Listing and Usage - Orals (plus non-parenteral) Products (CESW, LSNE & NWLN) CM_PHG_23_5697_01

Document No. 05a (v) - Product Listing & Usage - Hospital Only (Housekeeping) Products (DCE, DSW, DLS & DNE) CM_PHG_23_5697_03.xlsx

Document No. 05a (v) - Product Listing & Usage - Hospital Only (Housekeeping) Products (DCE, DSW, DLS & DNE) CM_PHG_23_5697_03

Document No. 00 - Read Me First Document.docx

Document No. 00 - Read Me First Document

Document No. 08 - Confidential information schedule.xls

Document No. 08 - Confidential information schedule

Document No. 09 - Stability Data Requirements.xlsx

Document No. 09 - Stability Data Requirements

Document No. 05a (ii) (iv) and (vi) CM_PHG_23_5697 Selectt Application.docx

Document No. 05a (ii) (iv) and (vi) CM_PHG_23_5697 Selectt Application

Document No. 02 - Terms of offer.doc

Document No. 02 - Terms of offer

Document No. 05b - Selectt offer schedule instructions.docx

Document No. 05b - Selectt offer schedule instructions

Document No. 04b - Assessment Criteria, Stability Protocol and Additional Specification Requirements.docx

Document No. 04b - Assessment Criteria, Stability Protocol and Additional Specification Requirements

Additional text

To express interest and participate in the tender, please register and apply via Atamis e-sourcing portal https://health-family.force.com/s/Welcome.

Should Tenderers have any queries, or having problems using the portal, they should contact Helpdesk at:

Phone: 0800 9956035

E-mail: support-health@atamis.co.uk

---

How to apply

Follow the instructions given in the description or the more information section.

---

About the buyer

Contact name

Gemma Tomlinson

Address

2nd Floor Rutland House
Runcorn
WA7 2ES
GB

Email

gemma.tomlinson1@nhs.net

---

Share this notice

Is there anything wrong with this page?